高血压患者KLRB1+IL7R+γδT细胞与GZMK的关系
The Relationship between KLRB1+IL7R+γδT Cells and GZMK in Patients with Hypertension
DOI: 10.12677/acm.2026.1672610, PDF,    科研立项经费支持
作者: 宿 昕:内蒙古自治区人民医院心血管内科,内蒙古 呼和浩特;内蒙古科技大学包头医学院研究生院,内蒙古 包头;郭欣君:内蒙古自治区人民医院心血管内科,内蒙古 呼和浩特
关键词: 高血压γδT细胞KLRB1IL7RGZMK颗粒酶KHypertension γδT Cells KLRB1 IL7R GZMK Granzyme K
摘要: 目的:探讨高血压患者外周血γδT细胞亚群变化及其与颗粒酶K (GZMK)水平的关系。方法:纳入前期高血压临床样本库中60例流式检测亚组研究对象,其中对照组30例、高血压组30例。采用流式细胞术检测γδT细胞比例及KLRB1+IL7R+γδT细胞比例,采用ELISA检测血清GZMK水平。结果:高血压组GZMK水平高于对照组(U = 276.0, P = 0.010)。γδT细胞总比例组间差异无统计学意义(U = 354.5, P = 0.160),但高血压组KLRB1+IL7R+γδT细胞比例升高(U = 311.0, P = 0.041)。KLRB1+IL7R+γδT细胞比例与GZMK水平呈弱正相关(r_s = 0.304, P = 0.018)。结论:高血压患者外周血KLRB1+IL7R+γδT细胞亚群升高,并与GZMK水平呈弱正相关,提示该亚群可能与高血压状态下GZMK相关免疫异常有关。由于本研究为小样本横断面研究,上述结果仅能提示关联,尚不能推断因果关系。
Abstract: Objective: To investigate changes in peripheral blood KLRB1+IL7R+γδT-cell subsets and their relationship with granzyme K (GZMK) levels in patients with hypertension. Methods: Sixty subjects from a previous clinical sample bank were included in the flow cytometry subgroup, including 30 controls and 30 hypertensive patients. Flow cytometry was used to detect the proportions of total γδT cells and KLRB1+IL7R+γδT cells, and serum GZMK levels were measured by ELISA. Results: Serum GZMK levels were higher in hypertensive patients than in controls (U = 276.0, P = 0.010). Total γδT-cell proportions showed no significant between-group difference (U = 354.5, P = 0.160), whereas KLRB1+IL7R+γδT-cell proportions were elevated in the hypertension group (U = 311.0, P = 0.041). KLRB1+IL7R+γδT-cell proportion was weakly positively correlated with serum GZMK level (r_s = 0.304, P = 0.018). Conclusion: Elevated KLRB1+IL7R+γδT-cell proportions and their weak positive correlation with serum GZMK suggest that this subset may be associated with GZMK-related immune dysregulation in hypertension. Given the small-sample cross-sectional design, these findings indicate associations rather than causality.
文章引用:宿昕, 郭欣君. 高血压患者KLRB1+IL7R+γδT细胞与GZMK的关系[J]. 临床医学进展, 2026, 16(7): 996-1003. https://doi.org/10.12677/acm.2026.1672610

参考文献

[1] 中国高血压防治指南修订委员会. 中国高血压防治指南(2024年修订版) [J]. 中华高血压杂志, 2024, 32(7): 603-700.
[2] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志, 2024, 39(7): 625-660.
[3] Li, Y., Teng, D., Shi, X., Teng, X., Teng, W., Shan, Z., et al. (2021) Changes in the Prevalence of Obesity and Hypertension and Demographic Risk Factor Profiles in China over 10 Years: Two National Cross-Sectional Surveys. The Lancet Regional HealthWestern Pacific, 15, Article ID: 100227. [Google Scholar] [CrossRef] [PubMed]
[4] Drummond, G.R., Vinh, A., Guzik, T.J. and Sobey, C.G. (2019) Immune Mechanisms of Hypertension. Nature Reviews Immunology, 19, 517-532. [Google Scholar] [CrossRef] [PubMed]
[5] Xiao, L. and Harrison, D.G. (2020) Inflammation in Hypertension. Canadian Journal of Cardiology, 36, 635-647. [Google Scholar] [CrossRef] [PubMed]
[6] Madhur, M.S., Elijovich, F., Alexander, M.R., et al. (2021) Hypertension: Do Inflammation and Immunity Hold the Key to Solving This Epidemic? Circulation Research, 128, 908-933. [Google Scholar] [CrossRef
[7] Caillon, A., Paradis, P. and Schiffrin, E.L. (2019) Role of Immune Cells in Hypertension. British Journal of Pharmacology, 176, 1818-1828. [Google Scholar] [CrossRef] [PubMed]
[8] Ribot, J.C., Lopes, N. and Silva-Santos, B. (2020) γδ T Cells in Tissue Physiology and Surveillance. Nature Reviews Immunology, 21, 221-232. [Google Scholar] [CrossRef] [PubMed]
[9] Kabelitz, D., Serrano, R., Kouakanou, L., Peters, C. and Kalyan, S. (2020) Cancer Immunotherapy with γδ T Cells: Many Paths Ahead of Us. Cellular & Molecular Immunology, 17, 925-939. [Google Scholar] [CrossRef] [PubMed]
[10] Papotto, P.H., Ribot, J.C. and Silva-Santos, B. (2017) IL-17+ γδ T Cells as Kick-Starters of Inflammation. Nature Immunology, 18, 604-611. [Google Scholar] [CrossRef] [PubMed]
[11] Li, Y., Jiang, S., Li, J., Yin, M., Yan, F., Chen, Y., et al. (2022) Phenotypic Changes of Peripheral γδ T Cell and Its Subsets in Patients with Coronary Artery Disease. Frontiers in Immunology, 13, Article ID: 900334. [Google Scholar] [CrossRef] [PubMed]
[12] Xu, L., Chen, F., Fan, W., Saito, S. and Cao, D. (2024) The Role of γδ T Lymphocytes in Atherosclerosis. Frontiers in Immunology, 15, Article ID: 1369202. [Google Scholar] [CrossRef] [PubMed]
[13] Bouwman, A.C., van Daalen, K.R., Crnko, S., ten Broeke, T. and Bovenschen, N. (2021) Intracellular and Extracellular Roles of Granzyme K. Frontiers in Immunology, 12, Article ID: 677707. [Google Scholar] [CrossRef] [PubMed]
[14] Duquette, D., Harmon, C., Zaborowski, A., Michelet, X., O’Farrelly, C., Winter, D., et al. (2023) Human Granzyme K Is a Feature of Innate T Cells in Blood, Tissues, and Tumors, Responding to Cytokines Rather than TCR Stimulation. The Journal of Immunology, 211, 633-647. [Google Scholar] [CrossRef] [PubMed]
[15] Richardson, K.C., Jung, K., Pardo, J., Turner, C.T. and Granville, D.J. (2022) Noncytotoxic Roles of Granzymes in Health and Disease. Physiology, 37, 323-348. [Google Scholar] [CrossRef] [PubMed]
[16] Turner, C.T., Zeglinski, M.R., Boivin, W., Zhao, H., Pawluk, M.A., Richardson, K.C., et al. (2023) Granzyme K Contributes to Endothelial Microvascular Damage and Leakage during Skin Inflammation. British Journal of Dermatology, 189, 279-291. [Google Scholar] [CrossRef] [PubMed]
[17] Fergusson, J.R., Smith, K.E., Fleming, V.M., Rajoriya, N., Newell, E.W., Simmons, R., et al. (2014) CD161 Defines a Transcriptional and Functional Phenotype across Distinct Human T Cell Lineages. Cell Reports, 9, 1075-1088. [Google Scholar] [CrossRef] [PubMed]
[18] Carrette, F. and Surh, C.D. (2012) IL-7 Signaling and CD127 Receptor Regulation in the Control of T Cell Homeostasis. Seminars in Immunology, 24, 209-217. [Google Scholar] [CrossRef] [PubMed]